Low urgency

Heated tobacco: FDA renews IQOS exposure-modification authorization - Vera Health

Detected July 6, 2026 · in Vape & Tobacco Retail Compliance

FDA renews IQOS exposure-modification authorization, maintaining its status as a modified risk tobacco product. No immediate action required for most retailers, but those selling IQOS must ensure compliance with existing marketing restrictions.

Aforeworn detected this change in the Vape & Tobacco Retail Compliance space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Vape shops and tobacco retailers selling IQOS products should confirm how it applies to their specific situation before acting. There is a time constraint attached: None. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Vape & Tobacco Retail Compliance continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

FDA renewed the exposure-modification order for IQOS, allowing continued marketing as a modified risk product. No new restrictions or requirements.

Who it affects

Vape shops and tobacco retailers selling IQOS products

What you must do

No new action required; continue to comply with existing FDA regulations for modified risk products.

Deadline

None

Source: https://news.google.com/rss/articles/CBMinAFBVV95cUxNOFJtMkVQbnYzdTcyWHpvYUVKeTNNeWp0OGR6alExNVdIU1psNzhrdWhaS09Cbkg2cVR6MWlQT0RIYUMwbUZZY3FyUjZKaDdjUkJuOVlqYmtKMVNZbE9FQUVCLXUyU1lvTkFJM0VkTWYzWUM0cWp6LTBOTEtxTmVGVmx6d3Rpa1hrY0xqLWhNNFEwRUt4c0tJQ1RQUWs?oc=5

Never miss a change like this again

Aforeworn watches Vape & Tobacco Retail Compliance around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Vape & Tobacco Retail Compliance